US Bancorp
APMD

US Bancorp’s Apnimed Inc APMD Stock Holding History

US Bancorp’s Portfolio APMD Stock Details APMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$307 Buy
+14
New +$377 ﹤0.01% 4162

Other funds holding APMD

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

US Bancorp's APMD Position: Q3 2026 in Review

US Bancorp opened a new position in Apnimed Inc (APMD) in Q3 2026: 14 shares worth $307. The stake represents ﹤0.01% of the portfolio and ranks #4162 among its holdings.

20 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • US Bancorp held 14 shares of Apnimed Inc worth $307 as of Q3 2026.
  • Apnimed Inc was a new US Bancorp position in Q3 2026.
  • Apnimed Inc made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #4162 holding.
  • 20 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.